Genetic Framework Flags Safety Risks for Inflammatory Bowel Disease Drug Targets
A new genetics-based framework systematically flags potential safety risks for inflammatory bowel disease drug targets before broad clinical exposure.
A new genetics-based framework systematically flags potential safety risks for inflammatory bowel disease drug targets before broad clinical exposure.
A nationwide Finnish study combining registry data, sibling comparisons and genome-wide analysis finds that infant RSV hospitalisation raises childhood wheezing ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine